Stay updated with breaking news from Roger Adsett. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investment analysts at Guggenheim assumed coverage on shares of Insmed (NASDAQ:INSM – Get Free Report) in a report released on Tuesday, MarketBeat reports. The brokerage set a “buy” rating and a $50.00 price target on the biopharmaceutical company’s stock. Guggenheim’s target price would indicate a potential upside of 145.10% from the stock’s current price. Separately, […]
Insmed Incorporated (NASDAQ:INSM – Free Report) – Cantor Fitzgerald issued their FY2024 earnings per share (EPS) estimates for shares of Insmed in a research note issued to investors on Tuesday, July 11th. Cantor Fitzgerald analyst J. Kim forecasts that the biopharmaceutical company will post earnings per share of ($4.67) for the year. The consensus estimate […]
Shares of Insmed Incorporated (NASDAQ:INSM – Get Free Report) have earned an average rating of “Buy” from the eleven ratings firms that are currently covering the company, MarketBeat.com reports. Eleven research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have covered the stock in the last […]
Insmed Incorporated (NASDAQ:INSM – Free Report) has been given an average recommendation of “Buy” by the eleven research firms that are presently covering the company, Marketbeat.com reports. Eleven equities research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have issued a report on the stock in […]
StockNews.com upgraded shares of Insmed (NASDAQ:INSM – Free Report) from a sell rating to a hold rating in a research note published on Friday. Insmed Price Performance Shares of NASDAQ:INSM opened at $21.10 on Friday. The stock has a market cap of $2.88 billion, a PE ratio of -4.94 and a beta of 1.53. The […]